Harnessing mRNA Therapeutic Platforms to Accelerate Product Development

Time: 2:15 pm
day: Day One Track A PM


  • Describing different platform components from design to manufacturing, and their importance to accelerating product development
  • Leveraging critical elements in protein and mRNA design to drive clinically relevant PK and purity behaviours in vivo
  • Transitioning from in vitro to rodents to non-human primates to best predict clinical efficacy in heterogeneous populations